Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F6ZHL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,461
Award facts
- Contract value 100% obligated
- $12,461.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,461.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of January 13, 2026. The contract was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a child entity under its parent company Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains. The current award for Repatha, a specialty pharmaceutical used in cardiovascular disease management, exemplifies the company's role in delivering essential medications to support military treatment facilities and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F6ZHL?
SPE2DR26F6ZHL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F6ZHL worth?
The government has obligated $12,461 on SPE2DR26F6ZHL.
Is contract SPE2DR26F6ZHL an order under another contract?
Yes. SPE2DR26F6ZHL is a delivery order under SPE2DR25D3803, an indefinite delivery contract.
Was contract SPE2DR26F6ZHL competed?
The extent of competition for SPE2DR26F6ZHL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award